CLL-derived NK cells are hypo-responsive towards K562 target cells, which correlates with reduced expression of the activating receptor NKG2D, an effect that could be induced in HC-derived NK cells by co-culture with CLL cells. The gene discussed is KLRK1; the disease is B-cell chronic lymphocytic leukemia.